首页> 外文期刊>Cephalalgia >Migraine incidence, comorbidity and health resource utilization in the UK.
【24h】

Migraine incidence, comorbidity and health resource utilization in the UK.

机译:英国的偏头痛发生率,合并症和医疗资源利用情况。

获取原文
获取原文并翻译 | 示例
       

摘要

Population-based data on migraine incidence and comorbidity are scarce. We therefore aimed to quantify incidence rates and comorbidity of diagnosed migraine and health resource utilization (HRU) in migraineurs in the UK primary care setting. We conducted a follow-up study with a nested case-control analysis on the General Practice Research Database. The study encompassed 51,688 patients with a first-time diagnosis of migraine between 1994 and 2001, and the same number of matched controls. The migraine incidence rate was 3.69 (95% confidence interval 3.66, 3.73) cases per 1000 person-years. It was around 2.5 times higher in women. Most chronic diseases were slightly more prevalent in migraineurs than in controls. Triptan users had higher health resource utilization than other migraineurs. This study shows that migraine is a common diagnosis in general practice and associated with a high prevalence of comorbidity. The increased HRU in triptan users suggests greater migraine severity.
机译:关于偏头痛发生率和合并症的基于人口的数据很少。因此,我们旨在量化在英国初级保健机构中偏头痛患者的诊断偏头痛和健康资源利用(HRU)的发生率和合并症。我们在“全科医学研究数据库”上进行了嵌套研究和病例对照分析。该研究纳入了1994年至2001年间首次诊断为偏头痛的51,688名患者,以及相同数量的匹配对照组。每1000人年的偏头痛发生率为3.69例(95%置信区间3.66、3.73)。女性的这一比例大约是女性的2.5倍。大多数慢性病在偏头痛人群中比在对照组中更为普遍。 Triptan使用者比其他偏头痛使用者的卫生资源利用率更高。这项研究表明,偏头痛是一般实践中的常见诊断,并与合并症高发有关。曲坦类药物使用者的HRU升高表明偏头痛严重程度更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号